PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Isolated bufadienolides showed cytotoxic activity against HL-60 and A549 cells (IC50 0.019 to 3.0 µM) [PMID:31991264] and MCF-7 human breast cancer cells (IC50 2.4 nM to >10 µM) [PMID:39549941]. Steroidal glycosides also showed cytotoxicity against HL-60 and A549 cells [PMID:32115535].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 31991264 (2020) — Bufadienolides from the whole plants of Helleborus foetidus and their cytotoxicity. · Phytochemistry
- 2.PMID: 39549941 (2025) — Bufadienolides from Helleborus foetidus and their cytotoxic properties on MCF-7 breast cancer cells. · Phytochemistry
- 3.PMID: 32115535 (2020) — Novel Steroidal Glycosides from the Whole Plants of Helleborus foetidus. · Chemical & pharmaceutical bulletin
- 4.PMID: 30812734 (2003) — First Report of Cucumber mosaic virus in Helleborus foetidus in France and Italy. · Plant disease
- 5.PMID: 2256246 (1990) — Helleborus foetidus poisoning of cattle. · The Veterinary record